gvtcx

supplier

Biogen

SL64AY

as a supplier

15 recorded awards from 2 buyers , between 7 Feb 2022 and 30 Jun 2025.

awards won
15
exclusive
0%
0 sole-winner awards
median award
£480.4m
largest
£986.3m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 shared NHS England £986,282,758 30 Jun 2025
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National shared NHS England £261,895,933 24 Jun 2025
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
Framework Agreement for the supply of Ranibizumab shared NHS England · 28 Mar 2023
National Framework Agreement for Adalimumab Injection 1 April 2023 shared NHS England · 24 Mar 2023
NHS Framework for Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England · 15 Mar 2023
NHS Framework Agreement for South of England Branded - Tranche B and Annual shared NHS England · 12 Aug 2022
NHS Framework for the North of England, Branded Medicine shared The NHS Commissioning Board (operating under the name of NHS England) · 1 Mar 2022
NHS Framework Agreement, Branded Medicines for London and South of England shared NHS England · 17 Sept 2021
NHS Framework Agreement, Branded Medicines for London and South of England shared NHS England · 17 Sept 2021
NHS Framework, North of England, Branded Medicines - Tranche A and Annual Tranche shared The NHS Commissioning Board (operating under the name of NHS England) · 2 Mar 2021
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies. shared The NHS Commissioning Board (operating under the name of NHS England) · 23 Feb 2021

every contract won by Biogen →